These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 34154568)
21. Risk Factors for Postischemic Stroke Epilepsy in Young Adults: A Nationwide Population-Based Study in Taiwan. Do PT; Chen LY; Chan L; Hu CJ; Chien LN Front Neurol; 2022; 13():880661. PubMed ID: 35669871 [TBL] [Abstract][Full Text] [Related]
22. Oxcarbazepine versus phenytoin monotherapy for epilepsy. Muller M; Marson AG; Williamson PR Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587 [TBL] [Abstract][Full Text] [Related]
23. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Nolan SJ; Tudur Smith C; Weston J; Marson AG Cochrane Database Syst Rev; 2016 Nov; 11(11):CD001031. PubMed ID: 27841445 [TBL] [Abstract][Full Text] [Related]
24. Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study. Mahamud Z; Håkansson S; Burman J; Zelano J Epilepsy Behav; 2021 Aug; 121(Pt A):108034. PubMed ID: 34004524 [TBL] [Abstract][Full Text] [Related]
25. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018. Yu L; Feng J; Yu Z; Dai H Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644 [TBL] [Abstract][Full Text] [Related]
26. Risk Factors and Temporal Patterns of Poststroke Epilepsy across Stroke Subtypes: Insights from a Nationwide Cohort Study in Korea. Ha WS; Jang K; Cho S; Kim WJ; Chu MK; Heo K; Kim KM Neuroepidemiology; 2024; 58(5):383-393. PubMed ID: 38599180 [TBL] [Abstract][Full Text] [Related]
27. Evolution of antiseizure medication use and cost in the United States of America 2006-2021. Sánchez Fernández I; Gaínza-Lein M; Amengual-Gual M; Barcia Aguilar C; Romeu A; Torres A; Jonas R; Douglass LM Seizure; 2023 Nov; 112():128-138. PubMed ID: 37832279 [TBL] [Abstract][Full Text] [Related]
28. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. Nolan SJ; Sudell M; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2016 Dec; 12(12):CD012065. PubMed ID: 27922722 [TBL] [Abstract][Full Text] [Related]
29. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. Nevitt SJ; Sudell M; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229 [TBL] [Abstract][Full Text] [Related]
30. Poststroke epilepsy incidence, risk factors and treatment: German claims analysis. Hardtstock F; Foskett N; Gille P; Joeres L; Molzan M; Wilson JC; Wilke T; Holtkamp M Acta Neurol Scand; 2021 Jun; 143(6):614-623. PubMed ID: 33626184 [TBL] [Abstract][Full Text] [Related]
31. Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30-year cohort study. Hakeem H; Alsfouk BAA; Kwan P; Brodie MJ; Chen Z Epilepsia; 2023 May; 64(5):1248-1258. PubMed ID: 36869855 [TBL] [Abstract][Full Text] [Related]
32. Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study. Olesen JB; Abildstrøm SZ; Erdal J; Gislason GH; Weeke P; Andersson C; Torp-Pedersen C; Hansen PR Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):964-71. PubMed ID: 21766386 [TBL] [Abstract][Full Text] [Related]
33. Effect of Statin Intensity on the Risk of Epilepsy After Ischaemic Stroke: Real-World Evidence from Population-Based Health Claims. Lin FJ; Lin HW; Ho YF CNS Drugs; 2018 Apr; 32(4):367-376. PubMed ID: 29619760 [TBL] [Abstract][Full Text] [Related]
34. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020. Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390 [TBL] [Abstract][Full Text] [Related]
35. Etiology-specific response to antiseizure medication in focal epilepsy. Doerrfuss JI; Kowski AB; Holtkamp M Epilepsia; 2021 Sep; 62(9):2133-2141. PubMed ID: 34328218 [TBL] [Abstract][Full Text] [Related]
37. Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide study. Larsson D; Åsberg S; Kumlien E; Zelano J Seizure; 2019 Jan; 64():29-33. PubMed ID: 30529757 [TBL] [Abstract][Full Text] [Related]
38. Statin use associated with lower risk of epilepsy after intracranial haemorrhage: A population-based cohort study. Lin HW; Ho YF; Lin FJ Br J Clin Pharmacol; 2018 Sep; 84(9):1970-1979. PubMed ID: 29714813 [TBL] [Abstract][Full Text] [Related]
39. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. Nolan SJ; Marson AG; Weston J; Tudur Smith C Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241 [TBL] [Abstract][Full Text] [Related]
40. Prescribed antiseizure medication doses and their relation to defined daily doses for achieving seizure freedom in newly diagnosed patients with epilepsy. Hersi H; Raitanen J; Saarinen JT; Peltola J Epilepsia Open; 2023 Sep; 8(3):811-819. PubMed ID: 37010264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]